FDA Agrees To A Tecarfarin-Warfarin Rematch, This Time Under "Real World" Conditions
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Aryx Therapeutics is working on a trial design to test its oral anticoagulant tecarfarin against warfarin under conditions "more typical in the practice of medicine," after the compound failed in a superiority study that may have managed warfarin users too well.